Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

Delayed Data
As of Mar 27
 +0.37 / +0.88%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 63.50, with a high estimate of 100.00 and a low estimate of 58.00. The median estimate represents a +49.94% increase from the last price of 42.35.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -44.71%
Growthannually -40.03%


Growthquarterly --
Growthannually 200.78%
Key to the earnings and sales forecast charts.